Henry Sebesta

Henry Sebesta, B.S.

Product & BD Manager
Product Development
KromaTiD, Inc.

Connect with me


Henry Sebesta is a dedicated life sciences industry professional with over 5 years of experience in gene therapy product and business development. Through years of market analysis and direct collaboration with thought leaders across the industry, Mr. Sebesta has helped guide the development of KromaTiD’s full suite of gene and cell therapy solutions. He is also a contributing author on KromaTiD’s ‘dGH for Gene Editing’ publication currently under review, and co-inventor on KromaTiD’s most recent IP for determining genotoxicity and relative risks of cell and gene therapies.